AI assistant
Iterum Therapeutics plc — Director's Dealing 2019
Jun 17, 2019
34796_dirs_2019-06-17_543597e9-3206-41db-8078-3bd276a12e09.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2019-06-13
Reporting Person: Heron Patrick J (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-13 | Stock Option (Right to Buy) | $6.74 | A | 9836 | Acquired | 2029-06-12 | Ordinary Shares (9836) | Direct |
| 2019-06-13 | Restricted Stock Units | $ | A | 2852 | Acquired | Ordinary Shares (2852) | Direct |
Footnotes
F1: Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Equity Incentive Plan, the shares subject to this option shall vest on June 13, 2020.
F2: Each restricted stock unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.
F3: Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Equity Incentive Plan, the RSUs shall vest on June 13, 2020.